Our study demonstrates an osteocyte NPY‐dependent neuronal control of BMSC fate decision and bone‐fat balance, and suggests that diet‐ or drug‐based therapy that favors ANS balance and reduces osteocyte NPY production is a promising therapeutic option against osteoporosis and skeletal aging. Here, NPY is linked to osteoporosis.